Palatin Technologies Inc logo

PTN - Palatin Technologies Inc Share Price

$0.82 -0.0  -3.9%

Last Trade - 25/02/21

Small Cap
Market Cap £138.8m
Enterprise Value £87.7m
Revenue £-320k
Position in Universe 4447th / 6713
Unlock PTN Revenue
Relative Strength (%)
1m -20.2%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -34.4%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
13.0 0.000 44.7 67.1 60.3 0.12 1.90 15.9 -60.9%
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 31 December 2020, PalatinTechnologies, Inc. revenues decreased from $118K to -$453K.Net loss increased 43% to $13.9M. Revenues reflect LicenseAnd Service decrease from $118K to $0K. Higher net lossreflects General and administrative increase of 74% to$7.4M (expense), Investment income decrease of 98% to $17K(income), Research and development increase of 9% to $6.9M(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


PTN Revenue Unlock PTN Revenue

Net Income

PTN Net Income Unlock PTN Revenue

Normalised EPS

PTN Normalised EPS Unlock PTN Revenue

PE Ratio Range

PTN PE Ratio Range Unlock PTN Revenue

Dividend Yield Range

PTN Dividend Yield Range Unlock PTN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
PTN EPS Forecasts Unlock PTN Revenue
Profile Summary

Palatin Technologies, Inc. (Palatin) is a biopharmaceutical company. The Company is engaged in developing medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. The Company’s product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical need and commercial potential. The melanocortin receptor (MCr) system is hormone driven, with effects on food intake, metabolism, sexual function, inflammation and immune system responses. There are five melanocortin receptors, MC1r through MC5r. The natriuretic peptide receptor (NPR) system regulates cardiovascular functions, and therapeutic agents modulating this system have potential to treat fibrotic diseases, cardiovascular diseases, including reducing cardiac hypertrophy and fibrosis, heart failure, acute asthma, pulmonary diseases and hypertension.

Last Annual June 30th, 2020
Last Interim December 31st, 2020
Incorporated November 21, 1986
Public Since December 21, 1999
No. of Shareholders: 106
No. of Employees: 20
Sector Healthcare
Industry Biotechnology & Medical Research
Exchange NYSE MKT
Shares in Issue 230,034,307
Free Float (0.0%)
Eligible for
PTN Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for PTN
Upcoming Events for PTN
Frequently Asked Questions for Palatin Technologies Inc
What is the Palatin Technologies Inc share price?

As of 25/02/21, shares in Palatin Technologies Inc are trading at $0.82, giving the company a market capitalisation of £138.8m. This share price information is delayed by 15 minutes.

How has the Palatin Technologies Inc share price performed this year?

Shares in Palatin Technologies Inc are currently trading at $0.82 and the price has moved by 53.34% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Palatin Technologies Inc price has moved by 23.12% over the past year.

What are the analyst and broker recommendations for Palatin Technologies Inc?

Of the analysts with advisory recommendations for Palatin Technologies Inc, there are there are currently 2 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Palatin Technologies Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Palatin Technologies Inc next release its financial results?

Palatin Technologies Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Palatin Technologies Inc dividend yield?

Palatin Technologies Inc does not currently pay a dividend.

Does Palatin Technologies Inc pay a dividend?

Palatin Technologies Inc does not currently pay a dividend.

When does Palatin Technologies Inc next pay dividends?

Palatin Technologies Inc does not currently pay a dividend.

How do I buy Palatin Technologies Inc shares?

To buy shares in Palatin Technologies Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Palatin Technologies Inc?

Shares in Palatin Technologies Inc are currently trading at $0.82, giving the company a market capitalisation of £138.8m.

Where are Palatin Technologies Inc shares listed? Where are Palatin Technologies Inc shares listed?

Here are the trading details for Palatin Technologies Inc:

Country of listing: United States
Exchange: ASQ
Ticker Symbol: PTN
What kind of share is Palatin Technologies Inc?

Based on an overall assessment of its quality, value and momentum, Palatin Technologies Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Palatin Technologies Inc share price forecast 2021?

Shares in Palatin Technologies Inc are currently priced at $0.82. At that level they are trading at 0.173% discount to the analyst consensus target price of 0.00.

Analysts covering Palatin Technologies Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.137 for the next financial year.

How can I tell whether the Palatin Technologies Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Palatin Technologies Inc. Over the past six months, the relative strength of its shares against the market has been 42.44%. At the current price of $0.82, shares in Palatin Technologies Inc are trading at 47.13% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Palatin Technologies Inc PE Ratio?

We were not able to find PE ratio data for Palatin Technologies Inc.

Who are the key directors of Palatin Technologies Inc?

Palatin Technologies Inc's management team is headed by:

Carl Spana - PRE
stephen Wills - CFO
John Prendergast - CHM
Robert deVeer - IND
Joseph Hull - IND
Alan Dunton - IND
Arlene Morris - IND
Anthony Manning - IND
Who are the major shareholders of Palatin Technologies Inc?

Here are the top five shareholders of Palatin Technologies Inc based on the size of their shareholding:

The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 4.12% (9.47m shares)
Vanguard Total Stock Market Index Fund Mutual Fund
Percentage owned: 2.64% (6.08m shares)
Acadian Asset Management LLC Investment Advisor/Hedge Fund
Percentage owned: 2.32% (5.34m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 1.62% (3.73m shares)
Spana (Carl) Individual Investor
Percentage owned: 1.56% (3.59m shares)
Similar to PTN
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.